Hlib Chabaniuk

Cellnex presents nine-month 2026 results after muted trading session

Cellnex presents nine-month 2026 results after muted trading session
Cellnex stock edges higher to €27.02

Cellnex presented results for the first nine months of 2026, highlighting a more than twofold increase in Free Cash Flow as organic growth, cost controls and lower investment intensity took hold. The stock edges higher on the day, trading at €27.02.

CLNX price prediction
24H -0.11%
€26.65
48H 0.19%
€26.73
7D 1.12%
€26.98
1M 11.54%
€29.76
3M 14.47%
€30.54
6M 17.05%
€31.23
12M -8.06%
€24.53
Current price: €26.68 -0.4100 1.51%
Closed 11/06
Daily range 26.31 Arrow from to Icon 27.15
Weekly range 25.83 Arrow from to Icon 27.26
Loading...

Highlights

  • Cellnex more than doubled Free Cash Flow in the first nine months of 2026 due to organic growth, cost controls and decreased investment intensity.
  • Revenue increased by 4.9% on an organic pro-forma basis, but Cellnex remains unprofitable with a trailing net loss of €343 million and EPS of -€0.52.
  • 67 of 95 analysts rate Cellnex stock a buy, with a median price target of $35, about 29.5% above the current level.

Cellnex presented its results for the first nine months of 2026. The company reported strong progress, citing a mix of organic growth, operating efficiencies and reduced investment intensity, which allowed it to more than double Free Cash Flow for the period. On an organic pro-forma basis, revenues increased by 4.9%.

Bullish structure holds as overbought signals emerge near resistance

Cellnex stock opened the session with a gap up from €26.83 to €26.97. The price is currently trading below the MA-200 at €27.18, but remains above both the MA-20 and MA-50, reflecting a split daily structure. RSI at 66.8 is nearing overbought territory, indicating the advance may be getting stretched. The daily move aligns with the broader bullish chart structure, but the test of overhead resistance remains in focus.

Upside probabilities dominate as traders watch the €27.18 level

A close above €27.18 would indicate buyers are willing to follow through on the current move. The session began with a strong gap higher, opening at €26.97 from a previous close of €26.83. From here, traders should consider that there is a 79% probability of further upside and a 21% probability of downside over the next five trading days, within an expected trading range of €26.35 to €27.68. Still, a sustained move higher with a firm trend has set the recent tone. A drop below €25.78 would show the move is being faded, while the longer-term picture on the weekly chart remains negative.

Earlier, analysts noted that broader market momentum and sector-specific catalysts were influencing trading direction, with traders closely watching economic releases and technical thresholds. The latest data from Cellnex adds a new dimension by highlighting organic expansion and cash flow improvement, putting focus on the €27.18 level as the key marker for any sustained upward move in the near term.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.